Manufacturer
Aurobindo Pharma Limited (Unit XII)
Contents
Piperacillin 4 g and Tazobactam 0.5 g
Indication
Empiric therapy for febrile neutropenic patients, Nosocomial pneumonia, Complicated intra-abdominal infections, Complicated urinary tract infections, Skin and soft tissue infections.
Instruction
IV Nosocomial pneumonia; Empiric therapy for febrile neutropenic patients 4.5 g 6 hrly for 5-14 days. Complicated intra-abdominal infections; Complicated urinary tract infections; Skin and soft tissue infections 4.5 g 8 hrly for 5-14 days.
Drug interaction
Interacts w/ high doses of heparin, oral anticoagulants or other drugs that affect blood coagulation or thrombocyte function. Prolongs the neuromuscular blockade of vecuronium and non-depolarising muscle relaxants. Prolongs half-lives w/ probenecid. Increased risk of methotrexate toxicity.
Malaysia
